Follow
Nathan Sepeda
Nathan Sepeda
Department of Psychiatry, Johns Hopkins University, Center for Psychedelic and Consciousness
Verified email at jhmi.edu - Homepage
Title
Cited by
Cited by
Year
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
AK Davis, FS Barrett, DG May, MP Cosimano, ND Sepeda, MW Johnson, ...
JAMA Psychiatry 78 (5), 481-489, 2021
10812021
Emotions and brain function are altered up to one month after a single high dose of psilocybin
FS Barrett, MK Doss, ND Sepeda, JJ Pekar, RR Griffiths
Scientific reports 10 (1), 2214, 2020
3012020
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
N Gukasyan, AK Davis, FS Barrett, MP Cosimano, ND Sepeda, ...
Journal of Psychopharmacology 36 (2), 151-158, 2022
2912022
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
MK Doss, M Považan, MD Rosenberg, ND Sepeda, AK Davis, PH Finan, ...
Translational psychiatry 11 (1), 574, 2021
2132021
People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences
MT Williams, AK Davis, Y Xin, ND Sepeda, PC Grigas, S Sinnott, ...
Drugs: Education, Prevention and Policy 28 (3), 215-226, 2021
1182021
Psychedelic treatment for trauma-related psychological and cognitive impairment among US special operations forces veterans
AK Davis, LA Averill, ND Sepeda, JP Barsuglia, T Amoroso
Chronic Stress 4, 2470547020939564, 2020
712020
Increases in psychological flexibility mediate relationship between acute psychedelic effects and decreases in racial trauma symptoms among people of color
AK Davis, Y Xin, ND Sepeda, A Garcia-Romeu, MT Williams
Chronic Stress 5, 24705470211035607, 2021
382021
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
SM Nayak, H Jackson, ND Sepeda, DS Mathai, S So, A Yaffe, H Zaki, ...
Frontiers in Psychiatry 14, 1199642, 2023
282023
Inhaled 5-methoxy-N, N-dimethyltryptamine: supportive context associated with positive acute and enduring effects
ND Sepeda, JM Clifton, LY Doyle, R Lancelotta, RR Griffiths, AK Davis
Journal of Psychedelic Studies 4 (2), 114-122, 2020
222020
Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans
SB Armstrong, Y Xin, ND Sepeda, M Polanco, LA Averill, AK Davis
Military psychology 36 (2), 184-191, 2024
112024
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial …
AW Levin, R Lancelotta, ND Sepeda, N Gukasyan, S Nayak, TL Wagener, ...
PloS one 19 (3), e0300501, 2024
102024
Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in …
AK Davis, Y Xin, N Sepeda, LA Averill
The American Journal of Drug and Alcohol Abuse 49 (5), 587-596, 2023
82023
Predictors of psychedelic treatment outcomes among special operations forces veterans.
Y Xin, SB Armstrong, LA Averill, N Sepeda, AK Davis
Psychology of Consciousness: Theory, Research, and Practice, 2023
52023
Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use
DS Mathai, DE Roberts, SM Nayak, ND Sepeda, A Lehrner, M Johnson, ...
PsyArXiv, 2023
32023
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers
DS Mathai, S Hilbert, ND Sepeda, JC Strickland, RR Griffiths, ...
Psychedelic Medicine 1 (4), 241-252, 2023
22023
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences
AK Davis, C Timmermann, AM Ortiz Bernal, R Lancelotta, S Nayak, ...
Journal of psychoactive drugs, 1-11, 2023
22023
The Epidemiology of Psychedelic Use Among United States Military Veterans
AK Davis, M Bates, EM Lund, ND Sepeda, AW Levin, SB Armstrong, ...
Journal of Psychoactive Drugs, 1-14, 2024
2024
Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin
R Lancelotta, C Timmerman, AMO Bernal, S Nayak, ND Sepeda, ...
Drug and Alcohol Dependence 260, 110861, 2024
2024
Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin Therapy
A Davis, A Levin, R Lancelotta, N Sepeda, N Gukasyan, S Nayak, ...
Drug and Alcohol Dependence 260, 110609, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–19